Provided by Tiger Trade Technology Pte. Ltd.

Amgen

439.33
+8.121.88%
Post-market: 439.05-0.2800-0.06%19:56 EDT
Volume:2.11M
Turnover:926.13M
Market Cap:236.57B
PE:27.29
High:440.51
Open:431.72
Low:429.38
Close:431.21
52wk High:443.20
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.82
T/O Rate:0.39%
Dividend:9.80
Dividend Rate:2.23%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:20.24
PE(LYR):30.87

Loading ...

Sino Biopharmaceutical Stock Advances 4.8% in Hong Kong

Dow Jones
·
Jul 02

Amgen’s AMG 133 Trial Adds a New Data Point in the Obesity Drug Race

TIPRANKS
·
Jul 02

Amgen Refines Its PCSK9 Franchise with New Evolocumab Bioavailability Study

TIPRANKS
·
Jul 02

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims & Hers Health (HIMS)

TIPRANKS
·
Jul 01

Micron, Palo Alto, Apple And A Health Care Stock On CNBC’s ‘Final Trades’

Benzinga_recent_news
·
Jul 01

CodeBreaK 100: Amgen’s KRAS Trial Update and What It Means for AMGN Investors

TIPRANKS
·
Jul 01

Medical Journal Retracts Paper on Amgen’s Tavneos Drug Trial After FDA Findings

Reuters
·
Jun 30

Trial used to approve Amgen’s Tavneos retracted from NEJM

TIPRANKS
·
Jun 30

Quantinuum Shares Slip Even as Brokerages Give "buy" Ratings After IPO Quiet Period

Reuters
·
Jun 30

Arrowhead Pharmaceuticals Posts Cardiometabolic R&D Webinar Presentation

Reuters
·
Jun 30

Viridian Therapeutics Exec Says the Wholesale Acquisition Cost for Five Infusions of Lumvoa is About $450,000 for a Typical 75‑kg Patient

THOMSON REUTERS
·
Jun 29

Viridian Therapeutics Exec Says Five Infusions of Its Thyroid Eye Disease Drug Lumvoa are Priced Roughly in Line with Eight Infusions of Amgen’s Tepezza - Conf Call

THOMSON REUTERS
·
Jun 29

Sino Biopharmaceutical Stock Rises 5.4% in Hong Kong

Dow Jones
·
Jun 29

US FDA Greenlights Viridian's Eye Disease Drug

Reuters
·
Jun 27

Amgen Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jun 27

Amgen's Tavneos Faces EU Revocation After CHMP Review

MT Newswires Live
·
Jun 26

U.S. Stocks on the Move-crocs, Amgen, Synaptics

Reuters
·
Jun 26

European Regulator Calls for Amgen's Tavneos to Have Authorization Revoked

Dow Jones
·
Jun 26

EMA Recommends Revoking Marketing Authorisation for Amgen's Rare Disease Drug

Reuters
·
Jun 26

EMA Recommends Revoking Marketing Authorisation for Tavneos in EU

Reuters
·
Jun 26